Clinical Trials

Top 3 Takeaways from December’s Facebook Live Event: “State of Clinical Trials and the Role of the Navigator”

Rosie Kelly
The state of clinical trials has been impacted by the COVID-19 pandemic. In December’s Facebook Live event, experts highlighted the integral role of the navigator in providing assessment, education, and support for patients with cancer who are considering their clinical trial options.

A Collaborative Effort to Increase AYA Clinical Trial Enrollment

Michael E. Roth, MD
Dr Michael Roth stresses the importance of understanding the interaction of providers, researchers, and navigators to more effectively improve AYA clinical trial enrollment.

Spreading Knowledge About AYA Clinical Trials

Michael E. Roth, MD
Dr Michael Roth talks about his efforts to increase knowledge about AYA clinical trial enrollment at the provider, nurse, and navigator levels.

The Navigator's Role in Increasing Clinical Trial Enrollment

Michael E. Roth, MD
Dr Michael Roth identifies how oncology nurse and patient navigators can significantly increase AYA clinical trial enrollment.

Overcoming Barriers to AYA Clinical Trial Enrollment

Michael E. Roth, MD
Dr. Michael Roth outlines some practical ways to increase AYA clinical trial enrollment.

Clinical Trials to Improve AYA Outcomes

Michael E. Roth, MD
Dr. Michael Roth believes that enhanced clinical trial enrollment will improve survival and quality of life for AYAs, and stresses the need to determine and overcome barriers to AYA clinical trial enrollment.

Accessibility of Clinical Trials to AYAs

Michael E. Roth, MD
Dr Michael Roth states that clinical trials are less accessible to adolescents and young adults than other populations for a variety of reasons. Watch the video to learn more.

Clinical Trial Enrollment for AYAs

Michael E. Roth, MD
Dr Michael Roth notes that clinical trial enrollment for adolescents and young adults is much lower than for younger patients and cites a need for greater understanding of barriers to enrollment.

Why Are Clinical Trials Important in the Fight Against Cancer?

Michael E. Roth, MD
Dr Michael Roth explains why clinical trials are critical to improving overall patient outcomes, including survivorship and quality of life.

Patient Misconceptions About Clinical Trials

Yelak Biru, MSc
Yelak Biru identifies some pervasive misconceptions and common barriers that exist regarding clinical trials.